| Literature DB >> 34326651 |
Henrique Diorio de Souza1,2, Eliane Azeka Hase3, Marco Aurelio Knippel Galletta1, Giselle Rodrigues Mota Diorio2, Adriana Lippi Waissman3, Rossana Pulcineli Vieira Francisco1, Marcelo Zugaib1.
Abstract
INTRODUCTION: Significant bacteriuria is associated with clinical and obstetric complications. The existing studies on the profile of urinary pathogens in pregnant women have widely divergent results and they hardly include data on pregnant adolescents.Entities:
Keywords: anti-bacterial agents; bacterial; bacteriuria; drug resistance; microbial sensitivity tests; pregnancy in adolescence; pregnant women
Year: 2021 PMID: 34326651 PMCID: PMC8316608 DOI: 10.2147/IDR.S310696
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Association Between Pregnant Female’s Age and Occurrence of Bacteriuria
| Characteristics | Bacteriuria | ||||
|---|---|---|---|---|---|
| Positive (%) | Negative (%) | Total (%) | ORa (CIb 95%) | p value | |
| - No | 258 (10.13) | 2289 (89.87) | 2547 (100) | ||
| - Yes | 66 (17.01) | 322 (82.99) | 388 (100) | 1.82 (1.35–2.44) | 0.0001*c |
Notes: *p value, statistically significant. cPerson Chi-Square.
Abbreviations: aOR, odds ratio; bCI, confidence interval.
Sociodemographic Characteristics and Obstetric History of Pregnant Adolescents and Adults Diagnosed with Bacteriuriaa
| Characteristics | Adolescents | Adults | |
|---|---|---|---|
| Mean or nb (±SDc or %) | Média ou nb (±SDc or %) | p value | |
| 15.29 ± 1.28 | 28.93± 6.06 | <0.001* | |
| 1.09± 0.34 | 2.25 ± 1.39 | <0.001* | |
| 0.06± 0.30 | 0.95 ± 1.11 | <0.001* | |
| 0.03± 0.17 | 0.27 ± 0.674 | <0.001* | |
| <0.001*d | |||
| - married/ stable relationship/ single with partner | 54 (81.82%) | 142 (55%) | |
| - single without a partner/ separated | 12 (18.18%) | 116 (45%) | |
| - yes | 3 (4.6%) | 17 (6.6%) | 0.775d |
| 23.30 ± 9.41 | 23.64 ± 9.28 | 0.752 |
Notes: aThe numbers do not always add up to the total due to absent values. dPerson Chi-Square. *p value, statistically significant.
Abbreviations: bn, number of individuals; cSD, standard deviation.
Main Pathogens Involved in the Occurrence of Bacteriuria Among the Pregnant Adolescents and Adults
| Bacteria | Number of Urine Cultures (%) - Adolescents | Number of Urine Cultures (%) - Adults |
|---|---|---|
| 49 (49) | 151 (42.18) | |
| 18 (18) | 72 (20.11) | |
| 7 (7) | 13 (3.63) | |
| 5 (5) | 15 (4.19) | |
| 5 (5) | 16 (4.47) | |
| 4 (4) | 47 (13.13) | |
| Coagulase-negative staphylococci | 3 (3) | 20 (5,0.9) |
| 3 (3) | 7 (2) | |
| 2 (2) | 6 (1.68) | |
| 1 (1) | - | |
| 1 (1) | - | |
| 1 (1) | - | |
| 1 (1) | 1 (0.28) | |
| - | 7 (2.0) | |
| - | 1 (0.28) | |
| - | 1 (0.28) | |
| - | 1 (0.28) |
Characteristics of the Urine Test of Adolescents and Adults When the Urine Culture Tested Positivea
| Characteristics of the Urine Test When the Urine Culture Tested Positive | Adolescents (n = 100) | Adults (n = 358) | ||
|---|---|---|---|---|
| Mean or nb (± SDc or %) | Mean or nb (± SDc or %) | ORd (CIe 95%) | p value | |
| 6.40 ± 0.79 | 6.29 ± 0.74 | 0.169 | ||
| 1.017 ± 0.006 | 1.018 ± 0.006 | 0.478 | ||
| - absent | 35 (62.5%) | 110 (55.8%) | ||
| - present | 21 (37.5%) | 87 (44.2%) | 1.31 (0.72–2.43) | 0.374f |
| - absent | 44 (78.6%) | 173 (87.8%) | ||
| - present | 12 (21.4%) | 24 (12.2%) | 0.51 (0.24–1.10) | 0.084g |
| 44.43± 40.45 | 22.74 ± 31.36 | <0.001* | ||
| 11.52 ± 25.27 | 6.40 ± 16.64 | 0.698 | ||
| - absent | 53 (94.6%) | 182 (92.4%) | ||
| - present | 3 (5.4%) | 15 (7.6%) | 1.46 (0.41–5.22) | 0.564g |
| - absent | 42 (75%) | 140 (71.1%) | 1 | |
| - phosphate crystals | 10 (17.9%) | 18 (9.1%) | 0.54 (0.23–1.26) | 0.15 |
| - calcium oxalate crystals | 3 (5.4%) | 32 (16.2%) | 3.20 (0.93–10.9) | 0.064 |
| - urate crystals | 1 (1.8%) | 7 (3.6%) | 2.10 (0.25–17.6) | 0.49 |
| - absent | 10 (17.9%) | 39 (19.8%) | 1 | |
| - numerous bacteria | 36 (64.3%) | 107 (54.3%) | 0.76 (0.35–1.68) | 0.50 |
| - rare bacteria | 7 (12.5%) | 41 (20.8%) | 1.50 (0.52–4.34) | 0.45 |
| - fungi | 3 (5.4%) | 10 (5.1%) | 0.85 (0.20–3.70) | 0.83 |
| 0.022*h | ||||
| - cocci or gram-positive bacillif | 27 (27%) | 110 (30.7%) | ||
| 67 (67%) | 195 (54.5%) | |||
| - Enterobacteria/gram-negative bacteria | ||||
| - | 4 (4%) | 47 (13.1%) | ||
| 2 (2%) | 6 (1.7%) |
Notes: aThe numbers do not always add up to the total due to absent values. fExcept Staphylococcus aureus and Enterococcus sp. gPerson Chi-Square. hFisher`s Exact Test. *p value, statistically significant.
Abbreviations: bn, number of individuals; cSD, standard deviation; dOR, odds ratio; eCI, confidence interval.
Microbial Resistance Profile of Gram-Negative Bacteria and Enterococcus Sp Isolated in the Urine of Pregnant Adolescents and Adults
| Resistance in the Antibiogram | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ADOa | ADUb | ADOa | ADUb | ADOa | ADUb | ADOa | ADUb | ADOa | ADUb | |
| nc (%) | nc (%) | nc (%) | nc (%) | nc (%) | nc (%) | nc (%) | nc (%) | nc (%) | nc (%) | |
| Nalidixic acid | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (8.2) | 16 (10.6) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Ampicillin | 3 (100) | 7 (100) | 0 (0) | 0 (0) | 22 (44.9) | 64 (42.4) | 7 (100) | 13 (100) | 1 (20) | 7 (46.7) |
| Penicillin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| AMCd | 2 (66.7) | 5 (71.4) | 0 (0) | 0 (0) | 9 (18.4) | 19 (12.6) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Cephalothin | 3 (100) | 5 (71.4) | 0 (0) | 0 (0) | 19 (38.8) | 72 (47.7) | 2 (28.6) | 0 (0) | 0 (0) | 0 (0) |
| Cefoxitin | 1 (33.3) | 4 (57.1) | 0 (0) | 0 (0) | 0 (0) | 7 (4.6) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Cefuroxime | 2 (66.7) | 5 (71.4) | 0 (0) | 0 (0) | 4 (8.2) | 7 (4.6) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Cefotaxime | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (2) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Ceftazidime | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (2) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Ceftriaxone | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (2) | 3 (2) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Cefepime | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (4.1) | 3 (2.0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Nitrofurantoin | 0 (0) | 5 (71.4) | 0 (0) | 0 (0) | 3 (6.1) | 11 (7.3) | 6 (85.7) | 6 (46.2) | 3 (60) | 10 (66.7) |
| SMZ/TMPe | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 9 (18.4) | 27 (17.9) | 0 (0) | 0 (0) | 3 (60) | 5 (33.3) |
| Norfloxacin | 0 (0) | 0 (0) | 0 (0) | 10 (21.3) | 0 (0) | 6 (4) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Ciprofloxacin | 0 (0) | 0 (0) | 0 (0) | 2 (4.3) | 1 (2) | 8 (5.3) | 0 (0) | 0 (0) | 0 (0) | 1 (6.7) |
| Levofloxacin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (2) | 1 (0.7) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Gentamicin | 2 (66.7) | 1 (14.3) | 1 (25) | 6 (12.8) | 2 (4.1) | 8 (5.3) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Streptomycin | 0 (0) | 0 (0) | 1 (25) | 10 (21.3) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
| Multisensitivity | 0 (0) | 0 (0) | 3 (75) | 28 (59.6) | 20 (40.8) | 50 (33.1) | 0 (0) | 0 (0) | 2 (40) | 1 (6.7) |
| ESBL | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (4.1) | 3 (2) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Abbreviations: aADO, adolescents; bADU, adults; cn, number of individuals; dAMC, amoxicillin/clavulanate; eSMZ/TMP, sulfamethoxazole/trimethoprim.
Microbial Resistance Profile of Gram-Positive and All Bacteria Isolated in the Urine of Pregnant Adolescents and Adults
| Resistance in the Antibiogram | Streptococcus agalactiae | All Bacterial Species Isolated in Urine | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| ADOa | ADUb | ADOa | ADUb | ADOa | ADUb | ADOa | ADUb | |||
| nc (%) | nc (%) | nc (%) | nc (%) | nc (%) | nc (%) | nc (%) | nc (%) | ORd (CIe 95%) | p value | |
| Nalidixic acid | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 4 (4) | 18 (5) | 1.27 (0.42–3.84) | 0.454 |
| Ampicillin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 35 (35) | 98 (27.4) | 0.70 (0.44–1.12) | 0.143 |
| Penicillin | 2 (100) | 5 (83.3) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (2) | 5 (1.4) | 0.69 (0.13–3.63) | 0.474 |
| AMCf | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 11 (11) | 30 (8.4) | 0.74 (0.36–1.53) | 0.428 |
| Cephalothin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 24 (24) | 82 (22.9) | 0.94 (0.56–1.58) | 0.819 |
| Cefuroxime | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 7 (7) | 17 (4.7) | 0.66 (0.27–1.64) | 0.388 |
| Cefotaxime | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (1) | 1 (0.3) | 0.94 (0.41–2.13) | 0.389 |
| Ceftazidime | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (1) | 0 (0) | 0.09 (0.004–2.29) | 0.218 |
| Ceftriaxone | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (2) | 3 (0.8) | 0.41 (0.07–2.51) | 0.300 |
| Cefepime | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (2) | 3 (0.8) | 0.37 (0.08–1.66) | 0.180 |
| Nitrofurantoin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 12 (12) | 34 (9.5) | 0.41 (0.07–2.51) | 0.470 |
| SMZ/TMPg | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 13 (13) | 33 (9.2) | 0.68 (0.34–1.35) | 0.279 |
| Norfloxacin | 0 (0) | 1 (16.7) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 17 (4.7) | 10.30 (0.6–172.8) | 0.105 |
| Ciprofloxacin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (1) | 11 (3.1) | 3.13 (0.40–24.60) | 0.223 |
| Levofloxacin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (1) | 1 (0.3) | 0.28 (0.017–4.47) | 0.389 |
| Gentamicin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 5 (5) | 15 (4.2) | 1.24 (0.46–3.37) | 0.451 |
| Streptomycin | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (1) | 10 (2.8) | 2.84 (0.36–22.49) | 0.268 |
| Multisensitivity | 0 (0) | 1 (16.7) | 5 (100) | 16 (100) | 18 (100) | 72 (100) | 52 (52) | 191 (53) | 1.05 (0.68–1.65) | 0.811 |
| ESBL | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (2) | 3 (0.8) | 0.41 (0.068–2.51) | 0.300 |
Abbreviations: aADO, adolescents; bADU, adults; cn, number of individuals; dOR, odds ratio; eCI, confidence interval; fAMC, amoxicillin/clavulanate; gSMZ/TMP, sulfamethoxazole-trimethoprim.